Just-In-Time is a rapid start-up process where research sites screens for patients prior to activation, this eliminates the significant delays in start-up and eliminate non-accruing sites. Only when a patient is pre-identified by a site by pre-screening or by AccessPPM the site activation process begins. Using TrialPlus+, Pharmatech can activate a site using sponsor or CRO CRA’s within just 10 business days, which includes contracting, budgets and regulatory documents – no other company can meet this level of efficiency. By opening centers only when a patient has been pre-identified, it eliminates non-accruing sites which represent approx. 30% of site opened traditionally in oncology studies.